Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Up 190.6% in May
by Amy Steele · The Cerbat GemTevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 6,937 shares, a growth of 190.6% from the May 14th total of 2,387 shares. Based on an average trading volume of 113,822 shares, the short-interest ratio is currently 0.1 days.
Tevogen Bio Price Performance
Shares of NASDAQ:TVGNW traded down $0.00 during trading on Friday, reaching $0.05. The company had a trading volume of 5,137 shares, compared to its average volume of 134,497. The company has a fifty day moving average of $0.04 and a two-hundred day moving average of $0.04. Tevogen Bio has a 12 month low of $0.03 and a 12 month high of $0.08.
Tevogen Bio Company Profile
Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.
The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.